Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.
Pilot clinical trial of NT-3 in CMT1A patients Zerife Sahenk; Olanzapine as maintenance therapy in patients with bipolar I disorder Mauricio Tohen and Daniel Yen Lin; Repetitive transcranial magnetic stimulation: a novel, noninvasive add-on treatment for medication-resistant depression Tung-Ping Su and Chih-Chia Huang; The NIMH MATRICS initiative: development of a consensus cognitive battery Robert S. Kern, Michael F. Green and Stephen R. Marder; A randomized trial comparing unilateral pallidotomy with bilateral subthalamic nucleus stimulation in PD: perspectives for future implication in clinical practice Rianne A. J. Esselink, Rob M. A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof and Johannes D. Speelman; Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of Risperidone monotherapy Srihari Gopal, John L. Beyer, David C. Steffens and Michelle L. Kramer; A double-blind, randomized clinical trial to assess the augmentation with Nimodipine of antidepressant therapy in the treatment of 'vascular depression' F. E. Taragano and P. M. Bagnati and R. F. Allegri; Combined behavioral and pharmacological treatment of opioid-dependent adolescents: a randomized, controlled trial Lisa A. Marsch; Comparative neuropsychological effects of Lamotrigine and Topiramate in healthy volunteers Kimford J. Meador; Can quality of life be improved in schizophrenia? Results from a pragmatic, randomized controlled trial comparing Olanzapine with first generation antipsychotics Mauricio Silva de Lima, Alan Breier and Jair de Jesus Mari; Review of a randomized-controlled trial of adjunctive Bupropion in the treatment of SSRI-induced sexual dysfunction Anna Lembke and Charles DeBattista; Trial-based advances in the treatment of bipolar depression David E. Kemp, Keming Gao, David J. Muzine, Prashant Gajwani and Joseph R. Calabrese; The Phase II futility clinical trial design Bernard Ravina and Yuko Palesch; Chemoradiotherapy for primary CNS lymphoma Antonio M. P. Omuro, Joachim Yahalom and Lauren E. Abrey; Clinical trials in dementia Raya-Ampil Cummings.
Zerife Sahenk, Mauricio Tohen, Daniel Yen Lin, Tung-Ping Su, Chih-Chia Huang, Robert S. Kern, Michael F. Green, Stephen R. Marder, Rianne A. J. Esselink, Rob M. A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof, Johannes D. Speelman, Srihari Gopal, John L. Beyer, David C. Steffens, Michelle L. Kramer, F. E. Taragano, P. M. Bagnati, R. F. Allegri, Lisa A Marsch, Kimford J. Meador Mauricio Silva de Lima, Alan Breier, Jair de Jesus Mari, Anna Lembke, Charles DeBattista, David E. Kemp, Keming Gao, David J. Muzine, Prashant Gajwani, Joseph R. Calabrese, Bernard Ravina, Yuko Palesch, Antonio M. P. Omuro, Joachim Yahalom, Lauren E. Abrey, Raya-Ampil Cummings